We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+7.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.9B
AUM Growth
+$1.55B
(+10%)
Cap. Flow
+$560M
Cap. Flow
% of AUM
3.31%
Top 10 Holdings %
Top 10 Hldgs %
18.6%
Holding
1,263
New
50
Increased
577
Reduced
391
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$57.5M |
| 2 |
Emerson Electric
EMR
|
+$45M |
| 3 |
Johnson & Johnson
JNJ
|
+$41.1M |
| 4 |
WEC Energy
WEC
|
+$36.5M |
| 5 |
Clorox
CLX
|
+$31.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PX
Praxair Inc
PX
|
+$63.8M |
| 2 |
Chevron
CVX
|
+$33.9M |
| 3 |
SLB Ltd
SLB
|
+$32.7M |
| 4 |
Lam Research
LRCX
|
+$22.8M |
| 5 |
Merck
MRK
|
+$21.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.91% |
| 2 | Healthcare | 16.61% |
| 3 | Financials | 14.79% |
| 4 | Communication Services | 9.7% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Kimco Realty
KIM
$16.2B
| $434K | ﹤0.01% |
23,400
+1,952
| +9% | +$32.8K |
|
|
ALDR
952
DELISTED
Alder Biopharmaceuticals
ALDR
| $432K | ﹤0.01% |
24,200
-600
| -2% | -$10.8K |
|
953
Jefferies Financial Group
JEF
$12.8B
| $429K | ﹤0.01% |
18,961
+1,641
| +9% | +$34.2K |
|
954
Coherus Oncology
CHRS
$192M
| $426K | ﹤0.01% |
21,300
-600
| -3% | -$10.6K |
|
955
Interface
TILE
$2.18B
| $426K | ﹤0.01% |
18,214
| – | – |
|
|
WCC
956
WESCO International
WCC
$17.9B
| $426K | ﹤0.01% |
7,008
| – | – |
|
957
Zillow
Z
$7.59B
| $423K | ﹤0.01% |
8,228
+527
| +7% | +$27.5K |
|
|
AIMT
958
DELISTED
Aimmune Therapeutics
AIMT
| $423K | ﹤0.01% |
15,100
-400
| -3% | -$11.3K |
|
959
Karyopharm Therapeutics
KPTI
$44.4M
| $419K | ﹤0.01% |
1,320
-33
| -2% | -$9.12K |
|
|
BOLD
960
DELISTED
Audentes Therapeutics, Inc
BOLD
| $418K | ﹤0.01% |
11,500
-300
| -3% | -$11.2K |
|
|
AAN.A
961
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $417K | ﹤0.01% |
8,471
-7,612
| -47% | -$375K |
|
|
FLG
962
Flagstar Bank National Association
FLG
$5.84B
| $415K | ﹤0.01% |
12,053
+747
| +7% | +$24.5K |
|
|
GHDX
963
DELISTED
Genomic Health, Inc.
GHDX
| $413K | ﹤0.01% |
6,800
-200
| -3% | -$11.7K |
|
964
KB Financial Group
KB
$42.4B
| $411K | ﹤0.01% |
9,202
| – | – |
|
965
Silicon Laboratories
SLAB
$7.2B
| $411K | ﹤0.01% |
4,200
| – | – |
|
|
CKH
966
DELISTED
Seacor Holdings Inc.
CKH
| $409K | ﹤0.01% |
7,958
| – | – |
|
|
NAV
967
DELISTED
Navistar International
NAV
| $408K | ﹤0.01% |
9,440
| – | – |
|
968
Assurant
AIZ
$14.2B
| $406K | ﹤0.01% |
3,711
-2,094
| -36% | -$222K |
|
969
NNN REIT
NNN
$8.8B
| $404K | ﹤0.01% |
8,048
-20,786
| -72% | -$935K |
|
|
TLRD
970
DELISTED
Tailored Brands, Inc.
TLRD
| $401K | ﹤0.01% |
+17,700
| New | +$407K |
|
971
Wipro
WIT
$19.7B
| $399K | ﹤0.01% |
207,819
| – | – |
|
972
Ovintiv
OVV
$17.6B
| $398K | ﹤0.01% |
5,967
+2,923
| +96% | +$189K |
|
|
AHT
973
Ashford Hospitality Trust
AHT
$20.7M
| $397K | ﹤0.01% |
61
| – | – |
|
974
Enanta Pharmaceuticals
ENTA
$402M
| $396K | ﹤0.01% |
4,400
-100
| -2% | -$10K |
|
975
Chord Energy
CHRD
$7.8B
| $390K | ﹤0.01% |
29,100
+13,466
| +86% | +$171K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q3 2018 Portfolio in Review
As of Q3 2018, DekaBank Deutsche Girozentrale held 1,263 positions worth $16.9B, up 10% from $15.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
DekaBank Deutsche Girozentrale deployed $560M of net new capital in Q3 2018, opening 50 new positions and adding to 577 existing holdings. Its largest new stake was Tilray: 8,950 shares worth $5.29M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Praxair Inc, an estimated $63.8M trimmed.
- DekaBank Deutsche Girozentrale's largest Q3 2018 buy was Tilray: 8,950 shares worth $5.29M.
- DekaBank Deutsche Girozentrale added most to Pfizer in Q3 2018, an estimated $57.5M increase.
- DekaBank Deutsche Girozentrale's biggest Q3 2018 reduction was Praxair Inc, cutting an estimated $63.8M.
- DekaBank Deutsche Girozentrale fully exited J.C. Penney Company, Inc. in Q3 2018, selling an estimated $3.94M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 19% of its $16.9B portfolio in Q3 2018.
- DekaBank Deutsche Girozentrale opened 50 new positions and closed 38 in Q3 2018.
- DekaBank Deutsche Girozentrale's portfolio value rose 10% quarter-over-quarter to $16.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2018, filed 9 Nov 2018.